News about Lab Equipment

AstraZeneca Advances Rare Disease Pipeline with Positive HPP Phase III Data

Alexion, AstraZeneca Rare Disease, has reported positive results from its global Phase III clinical programme evaluating efzimfotase alfa (ALXN1850) in patients with hypophosphatasia (HPP), a rare inherited metabolic disorder.

Lab Equipment | 01/04/2026 | By Darshana |  209

MiniMed Gets FDA Clearance for Smartphone-Controlled Insulin Pump Flex

MiniMed has received clearance from the US Food and Drug Administration (FDA) for its latest insulin delivery device, MiniMed Flex. The new system is a compact, smartphone-controlled insulin pump designed to make diabetes management less visible and easier to handle in everyday life.

Lab Equipment | 20/03/2026 | By Darshana |  166

Qiagen N.V. Receives U.S. Food and Drug Administration Clearance for QIAstat-Dx GI Panels on QIAstat-Dx Rise System

Qiagen N.V. has secured U.S. Food and Drug Administration clearance for QIAstat-Dx GI Panels on its QIAstat-Dx Rise system, enabling laboratories to run respiratory and gastrointestinal syndromic tests on a single automated platform.

Lab Equipment | 13/03/2026 | By News Bureau |  170

Chiesi Group Expands Partnership with Bespak to Scale Up Low-Carbon Inhaler Manufacturing

Chiesi Group and Bespak have expanded their partnership to boost pMDI manufacturing capacity in the UK, supporting the rollout of next-generation Carbon Minimal Inhalers designed to significantly reduce environmental impact.

Lab Equipment | 13/03/2026 | By News Bureau |  194

Novocure secures Japan insurance reimbursement for Optune Lua in advanced lung cancer treatment

Novocure receives reimbursement approval from Japan’s Ministry of Health, Labour and Welfare of Japan for Optune Lua, enabling insured access for advanced NSCLC patients using Tumour Treating Fields therapy.

Lab Equipment | 05/03/2026 | By News Bureau |  187

Astellas-Vir Partnership Advances Dual-Masked T-Cell Engager for Advanced Prostate Cancer

Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to develop and commercialize VIR-5500, an investigational PRO-XTEN dual-masked CD3 T-cell engager (TCE) targeting prostate-specific membrane antigen (PSMA) for the treatment of prostate cancer.

Lab Equipment | 25/02/2026 | By Darshana |  179

NOVOS Reports Positive Clinical Trial Results Showing Improvements in Vascular Aging Markers

A randomised clinical trial led by the University of Surrey found that NOVOS Core significantly improved endothelial function, arterial flexibility and systolic blood pressure in adults over 40 compared with placebo.

Lab Equipment | 20/02/2026 | By News Bureau |  599

Hologic's Aptima HPV Assay Receives US FDA Approval for Primary Cervical Cancer Screening

US FDA approves Hologic’s mRNA-based Aptima HPV assay for clinician-collected primary screening, expanding cervical cancer testing options and enhancing early detection of high-risk infections.

Lab Equipment | 07/02/2026 | By News Bureau |  201

Nanox Secures US FDA Clearance for TAP2D Image Enhancement Software for ARC Systems

FDA grants 510(k) clearance to Nanox’s cloud-enabled TAP2D software, enabling 2D image generation from a single tomosynthesis scan and advancing its strategy to position ARC systems as primary diagnostic solutions.

Lab Equipment | 05/02/2026 | By News Bureau |  526

OneSource Reports INR 47 Crore Net Loss in Q3 FY26 as Revenue Falls 26 Percent

OneSource Specialty Pharma reported a weak performance in the third quarter of FY26, posting a net loss of INR 47 crore for the quarter ended December 31, 2025. The company’s revenue declined 26 percent year on year to INR 290 crore, largely due to delays in converting a key service agreement into a commercial supply contract.

Lab Equipment | 27/01/2026 | By Darshana |  227